Literature DB >> 35655818

BDNF rs6265 single-nucleotide polymorphism is involved in levodopa-induced dyskinesia in Parkinson's disease via its regulation of the cortical thickness of the left postcentral gyrus.

Hui-Min Sun1, Li-Na Wang1, Min Ji1, Cai-Ting Gan1, Yong-Sheng Yuan1, Xing-Yue Cao1, Heng Zhang1, Ke-Zhong Zhang1.   

Abstract

Background: Brain-derived neurotrophic factor (BDNF) gene rs6265 single-nucleotide polymorphism (SNP) is thought to be involved in neuroplasticity and influence the development of levodopa-induced dyskinesia (LID) in Parkinson's disease (PD). This study aimed to determine how the BDNF rs6265 SNP regulates cortical thickness and to investigate the association between BDNF and the pathological mechanisms of LID in PD.
Methods: This cross-sectional study recruited 75 patients with PD, including 37 patients with LID and 38 patients without LID, and 33 healthy controls. All the participants underwent T1-weighted magnetic resonance imaging (MRI) scans, clinical evaluations, and BDNF rs6265 genotyping. Two-way factorial analysis of covariance (ANCOVA) was used to explore the primary effects of disease status, rs6265 genotype, and their interactions on cortical thickness. Associations between cortical thickness in the regions of the brain affected by disease status-genotype interactions and clinical symptoms were detected using Spearman's rank-order correlation. Receiver operating characteristic (ROC) curve analysis was used to test cortical thickness measurements as an indicator of LID.
Results: The main effects of disease status were observed in the right pars orbitalis (F=4.229, P=0.017), medial orbitofrontal cortex (F=3.639, P=0.030), and left banks superior temporal sulcus (F=3.172, P=0.046). The left pars orbitalis (F=4.541, P=0.036) and lingual gyrus (F=4.307, P=0.041) were thicker in carriers of the CC genotype than in carriers of the TC/TT genotype. Interaction between disease status and genotype showed that in the LID group, carriers of the CC genotype had a thicker left postcentral gyrus (mean difference =0.103, 95% confidence interval, 0.036 to 0.107, Bonferroni-corrected P<0.005) than did carriers of the TC/TT genotype, whereas no difference was found in the non-LID and healthy control (HC) groups. In carriers of the CC genotype, the cortical thickness of the left postcentral gyrus could identify whether patients with PD had LID, with an area under the receiver operating curve (AUC) of 0.757 (P=0.033, optimal cut-off =2.102). The cortical thickness of the left postcentral gyrus was also positively correlated with the Unified Dyskinesia Rating Scale (UDysRS) score in the LID-CC subgroup (r=0.825, P=0.001). Conclusions: The BDNF rs6265 SNP might be associated with dyskinesia symptoms in patients with PD and LID through its regulation of cortical thickness in the left postcentral gyrus. 2022 Quantitative Imaging in Medicine and Surgery. All rights reserved.

Entities:  

Keywords:  Brain-derived neurotrophic factor rs6265 (BDNF rs6265); Levodopa-induced dyskinesia (LID); Parkinson’s disease (PD); cortical thickness; imaging genetics

Year:  2022        PMID: 35655818      PMCID: PMC9131325          DOI: 10.21037/qims-21-1018

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN: 2223-4306


  41 in total

1.  Cortical surface-based analysis. I. Segmentation and surface reconstruction.

Authors:  A M Dale; B Fischl; M I Sereno
Journal:  Neuroimage       Date:  1999-02       Impact factor: 6.556

2.  Altered somatosensory cortex neuronal activity in a rat model of Parkinson's disease and levodopa-induced dyskinesias.

Authors:  Mesbah Alam; Regina Rumpel; Xingxing Jin; Christof von Wrangel; Sarah K Tschirner; Joachim K Krauss; Claudia Grothe; Andreas Ratzka; Kerstin Schwabe
Journal:  Exp Neurol       Date:  2017-04-23       Impact factor: 5.330

3.  The structural correlates of functional deficits in early huntington's disease.

Authors:  Christine Delmaire; Eve M Dumas; Michael A Sharman; Simon J A van den Bogaard; Romain Valabregue; Céline Jauffret; Damian Justo; Ralf Reilmann; Julie C Stout; David Craufurd; Sarah J Tabrizi; Raymund A C Roos; Alexandra Durr; Stéphane Lehéricy
Journal:  Hum Brain Mapp       Date:  2012-03-22       Impact factor: 5.038

4.  Gender effect on time to levodopa-induced dyskinesias.

Authors:  Sharon Hassin-Baer; Irena Molchadski; Oren S Cohen; Zeev Nitzan; Lilach Efrati; Olga Tunkel; Evgenia Kozlova; Amos D Korczyn
Journal:  J Neurol       Date:  2011-05-01       Impact factor: 4.849

5.  SNCA rs11931074 polymorphism correlates with spontaneous brain activity and motor symptoms in Chinese patients with Parkinson's disease.

Authors:  Qian-Qian Si; Yong-Sheng Yuan; Yan Zhi; Min Wang; Jian-Wei Wang; Yu-Ting Shen; Li-Na Wang; Jun-Yi Li; Xi-Xi Wang; Ke-Zhong Zhang
Journal:  J Neural Transm (Vienna)       Date:  2019-06-26       Impact factor: 3.575

6.  Effect of BDNF val(66)met polymorphism on declarative memory and its neural substrate: a meta-analysis.

Authors:  Joseph P Kambeitz; Sagnik Bhattacharyya; Lana M Kambeitz-Ilankovic; Isabel Valli; David A Collier; Philip McGuire
Journal:  Neurosci Biobehav Rev       Date:  2012-07-16       Impact factor: 8.989

7.  Influence of single nucleotide polymorphisms in COMT, MAO-A and BDNF genes on dyskinesias and levodopa use in Parkinson's disease.

Authors:  Perdita Cheshire; Kelly Bertram; Helen Ling; Sean S O'Sullivan; Glenda Halliday; Catriona McLean; Jose Bras; Tom Foltynie; Elsdon Storey; David R Williams
Journal:  Neurodegener Dis       Date:  2013-09-05       Impact factor: 2.977

8.  Meynert nucleus-related cortical thinning in Parkinson's disease with mild cognitive impairment.

Authors:  Siming Rong; Yan Li; Bing Li; Kun Nie; Piao Zhang; Tongtong Cai; Mingjin Mei; Lijuan Wang; Yuhu Zhang
Journal:  Quant Imaging Med Surg       Date:  2021-04

Review 9.  Actions of Brain-Derived Neurotrophin Factor in the Neurogenesis and Neuronal Function, and Its Involvement in the Pathophysiology of Brain Diseases.

Authors:  Tadahiro Numakawa; Haruki Odaka; Naoki Adachi
Journal:  Int J Mol Sci       Date:  2018-11-19       Impact factor: 5.923

10.  Risk factors of levodopa-induced dyskinesia in Parkinson's disease: results from the PPMI cohort.

Authors:  Paolo Eusebi; Michele Romoli; Federico Paolini Paoletti; Nicola Tambasco; Paolo Calabresi; Lucilla Parnetti
Journal:  NPJ Parkinsons Dis       Date:  2018-11-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.